Isracann Biosciences

CSE:IPOT
ISCNF
Request Investor Info

Isracann Biosciences is a newly listed company in an emerging market. Furthermore, they are Israel’s first pure-play cannabis firm, with a focus on becoming a premier, low-cost cannabis producer. In fact, Isracann is fully funded to execute on over 230,000 sq ft of hybrid greenhouse.

Projects
Stories
Presentation
Contact
Management
Financials
Isracann Biosciences Stock Price Today
Isracann Biosciences Fundamental Data by TradingView

Company Feed

Isracann Biosciences cannabis
Cannabis
November 27, 2019

Isracann: Set to Become a Major European Cannabis Supplier

Isracann Biosciences is a newly listed company in an emerging market. Furthermore, they are Israel’s first pure-play cannabis firm, with a focus on be …

This is some text inside of a div block.
Isracann Biosciences cannabis supplier
Cannabis
October 4, 2019

Isracann: Positioned to Become a Major Cannabis Supplier in Europe

The European cannabis market is five times bigger than the North American market. Isracann Biosciences is uniquely positioned to become a major suppli …

This is some text inside of a div block.
Subscribe and receive the investor Info